Loading clinical trials...

Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325 | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT02095860

Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325

The purpose of this study is to assess the effect of a high fat meal and light meal on the blood levels of Daclatasvir, Asunaprevir and BMS-791325 after administration of the 3 drugs as a fixed-dose c...

Lead sponsor: Bristol-Myers Squibb•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 4

Implementing Low-Barrier HCV Treatment in a Jail Setting

NCT06953479 · HEPATITIS C (HCV), Incarceration, and more

RECRUITINGNA

Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum

NCT04162938 · Hepatitis C

RECRUITINGNA

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

NCT03135886 · HIV/AIDS, Hepatitis C, and more

RECRUITINGNA

Persuasive Health Communication Intervention for HIV/HCV

NCT05968573 · Human Immunodeficiency Virus (HIV), Hepatitis C (HCV)

RECRUITING

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

NCT01644903 · Liver Transplant, Hepatitis C, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 10, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment24

Start dateApr 2014

Last updatedOct 10, 2014

Condition

Hepatitis C

Locations shown

Healthcare Discoveries, Llc D/B/A Icon Development Solutions

San Antonio, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 10, 2014Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Implementing Low-Barrier HCV Treatment in a Jail Setting

Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

Persuasive Health Communication Intervention for HIV/HCV

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

Trial snapshot

Condition

Locations shown

For caregivers